DO, MS, is a nephrologist and Professor of Medicine in the Division of Nephrology at the Icahn School of Medicine at Mount Sinai, where they care for patients at The Mount Sinai Hospital. They also serve as Associate Chair for Clinical and Translational Research in the Department of Internal Medicine and as Director of Clinical Research for the Division of Nephrology. Their clinical focus includes acute and chronic kidney care, dialysis-based kidney support, and the management of blood pressure, electrolyte, and acid-base disorders. Their research centers on translational nephrology, with particular interest in biomarker discovery and validation, artificial intelligence and risk stratification using large-scale clinical data, and precision approaches to clinical trial design and early intervention. Their work is driven by a commitment to advancing preemptive, personalized kidney care. A recognized leader in academic nephrology, they are Associate Editor of Kidney360, serve on the editorial boards of several leading nephrology journals, contribute to national research consortia, and frequently review grants for the National Institutes of Health. They are also a co-founder of Renalytix and helped pioneer a novel risk assessment platform in nephrology. Their honors include the American Society of Nephrology Midcareer Distinguished Researcher Award and reviewer awards from the American Journal of Nephrology and Kidney International. They earned their Doctor of Osteopathic Medicine from the University of New England College of Osteopathic Medicine, completed an internal medicine residency at Yale New Haven Hospital/Yale University School of Medicine, received an MS in Epidemiology and Public Health from Yale University, and completed a fellowship in nephrology at Yale New Haven Hospital/Yale University School of Medicine.
Professor
Medical School
1997 – 2001
Residency
2001 – 2004
Fellowship
2004 – 2008